Evolving physicians’ perceptions and practices regarding use of SGLT2 inhibitors for type 2 diabetes during Ramadan fasting-Reference-Cited by-同舟云学术

Evolving physicians’ perceptions and practices regarding use of SGLT2 inhibitors for type 2 diabetes during Ramadan fasting

Published:2020-10 Issue: Volume:168 Page:108389
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Beshyah Salem A.,Hafidh Khadija,Shaikh Tariq Gul

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence;Davidson;Postgrad Med,2019

2. Advances in the management of diabetes: therapies for type 2 diabetes [published online ahead of print, 2020 May 28];Tsoutsouki;Postgrad Med J,2020

3. Positioning SGLT2 inhibitors/incretin based therapies in the treatment algorithm;Wilding;Diabetes Care,2016

4. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies;Diabetologia,2018

5. Standards of medical care in diabetes-2020 abridged for primary care providers;American Diabetes Association;Clin Diabetes,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Knowledge and Perception of Sodium-Glucose Co-transporter 2 (SGLT-2) Inhibitors prescription Among Physicians in Saudi Arabia;Current Diabetes Reviews;2023-07-06

2. Knowledge gaps and perceptions of future research directions on management of diabetes during Ramadan fasting: An online survey of physicians;Diabetes Research and Clinical Practice;2021-07